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Implication for health policy/practice/research/medical education:
This research showed that lavender inhalation can effectively decrease primary dysmenorrhea. The potential application of this 
therapy is of interest due to no evidence of adverse event and low cost. 
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Introduction: Primary dysmenorrhea is defined as painful menses with cramping sensation 
in the lower abdomen with normal ovulatory cycles which has no pelvic pathology. This study 
aimed to evaluate the effect of inhalation of Lavandula angustifolia (lavender) essential oil on 
alleviating primary dysmenorrhea. 
Methods: This randomized double-blinded clinical trial included 96 students (48 in lavender 
and 48 in placebo groups) from Tehran University of Medical Sciences, Tehran, Iran. Single 
students with regular menstrual cycles suffering from primary dysmenorrhea regarding 
the verbal multi-dimensional scoring system were included. The intervention group was 
administered to inhale lavender essential oil (diluted in sesame oil in 2:1 ratio). The control 
group only inhaled sesame essential oil. The visual analogue scale (VAS) was used to assess the 
pain score at the baseline and 1, 2, 4, and 48 hours after intervention. Generalized estimation 
equations method was used for data analysis. 
Results: The students’ mean ± standard deviation (SD) age was 20.32±1.38 years. No 
significant difference was found in demographic and menstrual characteristics between 
groups. The mean VAS was not significantly different between groups at the baseline. Lavender 
inhalation reduced the mean±SD primary dysmenorrhea score of 2.92±0.2 according to VAS 
significantly during 48 first hours adjusted for baseline VAS (P < 0.001).
Conclusion: It could be concluded that lavender inhalation can decrease primary 
dysmenorrhea. The observed effectiveness of lavender inhalation as an inexpensive therapy 
without evidence of adverse event supports the interest for potential application of this 
therapy. 
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A B S T R A C T
Introduction
Dysmenorrhea is the most common gynecologic disorder 
in women of reproductive age which is categorized into 
primary and secondary ones. Primary dysmenorrhea 
is defined as painful menses with cramping sensation 
in the lower abdomen with normal ovulatory cycles 
every month during the reproductive years with menses 
in the absence of identifiable pelvic pathology (1). 
Dysmenorrhea accompanies spasmodic cramping pain in 
the inferior quadrants of the abdomen which radiates to 
the inner thigh (2). It usually begins a few hours before 
menstruation or contemporaneously at the beginning and 
lasts for 2-3 days (3). Dysmenorrhea symptoms usually 
start 6–12 months after menarche (4). Dysmenorrhea 
prevalence reaches its peak in the late teens or early 
twenties (5). Dysmenorrhea prevalence is nearly reported 
in 3/4 of women (6). In addition, dysmenorrhea rate 
varies between 45% to 95% in menstruating women (7). 
The prevalence of dysmenorrhea among the students is 
84% in Turkey (8) and 73.2% in 15-18 years old Iranian 
female subjects, of whom 15% missed school 1-7 days (9). 
Dysmenorrhea has a negative impact on female’s quality of 
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life including activity limitation and absence from school 
(7). In a study, sixty percent of the Canadian women 
experienced primary dysmenorrhea of whom 51% had 
limited activities and 17% reported to miss school or work 
(10). 
There are several treatments to relieve primary 
dysmenorrhea such as consumption of non-steroidal anti-
inflammatory drugs (NSAIDs) and oral contraceptives 
(11). The low level of female satisfaction is reported for 
NSAIDs due to a failure rate of 20-25% and non-tolerable 
side effects (12) addition to increase in cardiovascular 
disease risks (13).
In addition, complementary and alternative medicine 
for dysmenorrhea including herbal supplements, exercise, 
acupuncture, acupressure, spinal manipulation, and 
aromatherapy have been utilized for dysmenorrhea (14-
17). Aromatherapy, the therapeutic use of plant-derived 
concentrated essences (18,19), is commonly used in 
nursing practice to relieve the abdominal pains and to 
improve quality of life (20).
From hundreds of different lavenders, the most popular 
species grown for oil extraction is Lavandula angustifolia 
(21). Essential oils can be used in massage, bathing, and 
inhalation. Inhalation of essential oils stimulates olfactory 
receptor cells which results in sending impulses to the 
limbic system (22). Lavender as a sedative, anxiolytic, 
and mood modulator aromatherapy has major clinical 
benefits for the central nervous system (23). Essential 
oils could have relaxing and energizing effects which lead 
to pain treatment and palliative care development (24). 
It has been shown that aromatherapy is a safe and no 
pharmacologic treatment to relieve dysmenorrhea (25). 
In addition, Iranian females prefer complementary and 
alternative medicine to other methods for gynecological 
disorders treatment (26). Moreover, due to the high 
prevalence of dysmenorrhea, low efficacy of drugs and 
their side effects, this study was conducted to assess the 
effect of lavender inhalation as complementary medicine 
on primary dysmenorrhea in female students.
Materials and Methods 
In this double-blinded clinical trial, 96 dormitory resistant 
students in Tehran University of Medical Sciences, Tehran, 
Iran were recruited. Single students aged from 18 to 28 
years suffered from primary dysmenorrhea with score 
of two or three regarding Andersch & Milsom’s verbal 
multidimensional scoring system (27) were included. 
In addition, students with regular menstrual cycles, a 
normal sense of smell, no history of allergy to fragrances, 
having no history of contraceptives use were included. 
Students with absence of myoma, fibrocystadenoma, 
endometriosis, chronic pelvic inflammatory disease, 
obstructive vaginal or uterine congenital anomalies, 
ovarian cysts, chronic pelvic pain, metrorrhagia, systemic 
disease (irritable bowel syndrome, inflammatory bowel 
disease), and adenomyosis were qualified to recruit. 
Students who used analgesics to overcome dysmenorrhea 
or claimed having allergy to lavender were excluded. The 
students with primary dysmenorrhea; mild and moderate 
dysmenorrhea were recruited. Mild dysmenorrhea was 
considered as a painful menstruation that rarely inhibited 
the woman’s normal activity, however it was sometimes 
necessary to take analgesics. In moderate dysmenorrhea, 
daily activities are affected and analgesics are needed, 
however work or school is usually not missed (27). The 
students were followed for two menses as the baseline to 
detect primary dysmenorrhea.
Barij Essence Pharmaceutical Company (Kashan, Iran) 
provided the drug which was lavender aroma diluted in 
sesame oil with a ratio of 2:1. The placebo was only sesame 
oil. Students were randomly assigned into either placebo 
or lavender for two consecutive cycles. The students were 
instructed to strew 3 drops of the essential oil or placebo 
on their palms and inhale it for 5 minutes at the distance 
of 7-10 cm from nose at the start of dysmenorrhea and 
every six hours until three days. 
Details about sample size determination, randomization, 
and blinding can be found in (28). Demographic 
characteristics and menstrual characteristics were 
obtained. The pain level was assessed by visual analogue 
scale (VAS) ranges from 0 (no pain) to 10 (severe) (29) at 
baseline (1 hour before treatment), 1, 2, 4, and 48 hours.
The qualitative and quantitative variables described 
through frequency tables and mean and standard 
deviation (SD), respectively. Independent sample t test 
and chi-square tests were utilized. Due to the repeated and 
correlated nature of VAS measures, generalized estimating 
equation (GEE) method was used to assess the effect of 
lavender on VAS. Data were analyzed using SPSS 16. P 
value less than 0.05 was considered statistically significant.
Results
Ninety-six students who met the inclusion criteria were 
recruited the study: 48 in placebo and 48 in lavender groups. 
Consort diagram is shown in Figure 1. The student’s mean 
± SD age was 20.32±1.38 years. No significant difference 
was found in demographic and menstrual characteristics 
between groups (Table 1).
Figure 2 shows that the mean VAS in lavender group is 
noticeably lower than the placebo group in both cycles. 
Table 2 shows that in cycle one, the mean VAS was not 
different significantly between groups at the baseline 
(P = 0.06), however in cycle two, the baseline VAS was 
significantly lower in the lavender group (P = 0.024). For 
other time points in both cycles, the VAS mean in the 
lavender group was significantly lower than the placebo 
group (P < 0.001).
Table 3 shows that the students in the lavender group 
experienced a significantly lower VAS compared with 
the placebo group over time adjusted for baseline 
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VAS: -2.92±0.2 and -2.73±0.17 in cycles one and two, 
respectively (P < 0.001). Combining all data including 
cycle one and cycle two, the results revealed that the 
lavender inhalation reduced VAS 2.96±0.1 units over time 
in comparison to the placebo group (P < 0.001).
Discussion
This study focused on investigating the effect of lavender 
inhalation on alleviating primary dysmenorrhea. It was 
found that lavender inhalation significantly decreased the 
severity of dysmenorrhea about three scores in students 
according to 10-point VAS. In this regards, lavender oil 
has also shown to decrease the severity of dysmenorrhea 
(30). Inhalation of essential oils extracted from plants 
stimulate some olfactory receptor cells and the emotional 
center of the brain (31). A 10-minute lavender inhalation 
results in an increase in blood flow indicating a reduction 
in sympathetic nervous activity (32). In addition, the effect 
of aromatherapy using lavender essential oil on cesarean 
postoperative pain was studied such that the intervention 
group inhaled 3 drops of 10% lavender oil and the placebo 
group inhaled 3 drops of a base of aromatherapy blend 
without lavender essence for 5 minutes at the beginning 
of the postoperative pain, 4, 8, and 12 hours later. It 
was found the pain reduction after treatment use, then 
concluded that lavender inhalation could be as a part of 
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Assessed for eligibility (n=300) 
Excluded (n= 187) 
Declined participants the study 
(n=50) 
 Level one or four primary 
dysmenorrhea (n= 125) 
No meeting other inclusion criteria 
(n=12) 
4 lost cases were substituted  
Analysed (n=48) 
 
Lost to follow-up 
Catch cold and using adult cold (n=2), 
migration (n=1), Using analgesic (n=1) 
Allocated to lavender (n= 48) 
Received allocated intervention (n=48) 
Lost to follow-up  
Using analgesic (n=4), Allergy to 
sesame oil (n=2), Getting married (n=1), 
Amenorrhoea (n=1) 
 
Allocated to placebo (n= 48) 
Received allocated intervention (n=48) 
8 lost cases were substituted Analysed 
(n=48) 
96 (needed sample size) 
students were chosen 
(from n=113) and 
randomized  
Figure 1. Consort diagram of the study.
Table 1. Baseline characteristics in the lavender and the control groups
Characteristic Category Control group Lavender group
Onset of dysmenorrhea
One day before or simultaneously 38 (79.2%) 37 (77.1%)
Some days before 10 (20.8%) 11 (22.9%)
Family history of dysmenorrhea
Yes 44 (91.7%) 42 (87.5%)
No 4 (8.3%) 6 (12.5%)
Frequency of painful menstruation
Always 15 (31.2%) 14 (29.2%)
Most times 29 (60.4%) 25 (52.1%)
Sometimes 4 (8.3%) 9 (18.8%)
Age (±SD), year - 20.29 (±1.35) 20.35 (±1.43)
Age at menarche (±SD), year - 14 (±1.28) 13.68 (±1.25)
Age at onset of dysmenorrhea (±SD), year - 14.85 (±1.62) 14.47 (±1.48)
Duration between 2 menstruations (±SD), day - 28.25 (1.19) 28.31 (1.50)
Bleeding duration (±SD), day - 6.10 (0.95) 5.93 (1.21)
Pain duration (±SD), day - 2.25 (0.75) 2.43 (0.64)
BMI (±SD), kg/m2 - 21.89 (3.93) 20.97 (2.03)
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the multidisciplinary treatment of postoperative pain 
(33). Barocelli et al revealed a significant effect of lavender 
inhalation in controlling chemical and thermal pain in 
animal models without any observed side effect (34).
Soltani et al showed the effect of lavender inhalation 
on pediatric patients aged 6–12 years who underwent 
tonsillectomy surgery. The patients were administered to 
distil 4 drops of the lavender essential oil and inhaled for 
3 minutes every 6 hours. Their results demonstrated that 
lavender inhalation decreased the number of required 
analgesics following tonsillectomy (35). However, 
opposite results have also been found by Shahnazi et al 
who studied the effect of lavender aroma in intrauterine 
Figure 2. Error bar for VAS in lavender and placebo groups in cycle (a) 
one (b) two.
Table 2. Mean VAS±SD in lavender and placebo groups in all time points
Cycle Time point Placebo group (n = 48)
Lavender group 
(n = 48) P
One Baseline 6.39±1.65 5.7±1.86 0.06
1st hour 6±1.57 3.35±1.79 <0.001
2nd hour 5.97±1.64 1.85±1.58 <0.001
4th hour 5.04±1.96 0.95±1.27 <0.001
48th hour 3.2±1.74 0.25±0.81 <0.001
Two Baseline 6.25±1.59 0.52±1.52 0.024
1st hour 5.35±1.6 1.97±1.36 <0.001
2nd hour 4.04±1.55 0.47±0.82 <0.001
4th hour 3.5±1.65 0.31±0.62 <0.001
48th hour 2.66±1.52 0.2±0.41 <0.001
Table 3. The effect of lavender on VAS using GEE method
Cycle Source of variation Mean difference (SE) P
One Group (Lavender vs control) -2.92 (0.2) <0.001
Time -0.03 (0.003) <0.001
Group* Time 3.14 (0.01) <0.001
Baseline 0.39 (0.08) <0.001
Two Group (Lavender vs control) -2.73 (0.17) <0.001
Time -.02 (0.002) <0.001
Group* Time 3.8 (0.014) <0.001
Baseline 0.44 (0.06) <0.001
Total Group (Lavender vs control) -2.96 (0.16) <0.001
Time -.0.03 (0.002) <0.001
Group* Time 3.75 (0.12) <0.001
Baseline 0.43 (0.07) <0.001
GEE, generalized estimating equation.
device placement pain which resulted in nonsignificant 
effect of lavender inhalation (36). Furthermore, Salamati 
et al showed no significant effect of lavender inhalation 
(throughout the oxygen mask) on the reduction of pain 
after open-heart surgery (37). These opposite findings are 
likely due to the differences between the mechanism of 
pains as well as the inhalation method.
Anti-inflammatory property of lavender might be 
attributed to inhibition of prostaglandin synthesis (38). 
Also Aromatherapy triggers the limbic system which 
can result in pain reduction. Furthermore, the lavender 
has a sedative effect that inhibits the prostanoid system 
involving the production of prostaglandins E2 and F2α in 
the uterus (39). No adverse effects were observed in the 
present study, however, Han et al observed skin irritation 
in their study through lavender massage (40).
Finally, it is noteworthy that in the present randomized 
clinical trial also lavender inhalation relieved the 
severity of symptoms of dysmenorrhea such as tiredness, 
weakness, diarrhea, and headache. However, the amount 
of menstrual bleeding was not affected by lavender. 
It is highly recommended to apply the numerical or 
verbal rating scales instead of VAS for future researches 
due to its difficulties in use as well as a high failure rate 
(41).
Conclusion
It can be concluded that the lavender inhalation is able to 
decrease menstrual pain according to 10-point VAS. The 
observed effectiveness of lavender inhalation in primary 
dysmenorrhea reduction as an inexpensive therapy 
without evidence of adverse event supports the interest 
for potential application of this therapy. 
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